CLEAR stock drops 15% by October 2026 amid regulatory scrutiny on biometric data

CLEAR CEO Caryn Seidman Becker's presence at the health summit suggests defensive positioning despite ongoing controversies. New York State Attorney General's office is investigating CLEAR's data privacy practices, which could lead to restrictions or fines impacting stock performance.

Implied probability (Yes)

60%